(Q41009177)

English

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival

scientific article published on 30 December 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

25 September 2017

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival (English)

1 reference

Europe PubMed Central

25 September 2017

single-nucleotide polymorphism

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Emmanuel Chautard

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Catherine Vaurs-Barrière

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Philippe Arnaud

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

author name string

Mélanie Müller-Barthélémy

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Franck Court

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Afonso Almeida Pinto

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Jean-Louis Kémény

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Toufic Khalil

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Lucie Karayan-Tapon

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Pierre Verrelle

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

0 references

publication date

30 December 2015

1 reference

Europe PubMed Central

25 September 2017

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

37

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

169-176

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

MGMT gene silencing and benefit from temozolomide in glioblastoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Prognostic significance of molecular markers and extent of resection in primary glioblastoma patients

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

IDH1 and IDH2 mutations in gliomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

A distinct region of the MGMT CpG island critical for transcriptional regulation is preferentially methylated in glioblastoma cells and xenografts.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBM

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

The T genotype of the MGMT C>T (rs16906252) enhancer single-nucleotide polymorphism (SNP) is associated with promoter methylation and longer survival in glioblastoma patients

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

O-methylguanine-DNA methyltransferase (MGMT) mRNA expression predicts outcome in malignant glioma independent of MGMT promoter methylation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Malignant astrocytic glioma: genetics, biology, and paths to treatment

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Patients with high-grade gliomas harboring deletions of chromosomes 9p and 10q benefit from temozolomide treatment

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Altered expression of MGMT in high-grade gliomas results from the combined effect of epigenetic and genetic aberrations

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

The A/G allele of rs16906252 predicts for MGMT methylation and is selectively silenced in premalignant lesions from smokers and in lung adenocarcinomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: a potential biomarker for human sensitivity to alkylating agents

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Prognostic value of IDH1 mutations identified with PCR-RFLP assay in acute myeloid leukemia patients

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Genome Alteration Print (GAP): a tool to visualize and mine complex cancer genomic profiles obtained by SNP arrays

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Clinical impact of molecular biomarkers in gliomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

MGMT testing--the challenges for biomarker-based glioma treatment

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Prognostic value of three different methods of MGMT promoter methylation analysis in a prospective trial on newly diagnosed glioblastoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Do multiple outcome measures require p-value adjustment?

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGV251

21 January 2018

Identifiers

10.1093/CARCIN/BGV251

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26717998%20AND%20SRC:MED&resulttype=core&format=json

10 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41009177&oldid=2092972583"